Lupin’s Nagpur Facility Earns US FDA Approval After Flawless Inspection

Unknown Apr 02, 2026 450 Views

Lupin Limited has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its injectable facility in Nagpur. The EIR was issued following a successful inspection conducted from June 10 to June 13, 2024, which concluded with zero observat...